These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 2426566)
1. [Chronology of recurrent gastric cancer]. Takahashi Y; Mai M; Ogino T; Ueda H; Ueno M; Kusama S Nihon Geka Gakkai Zasshi; 1986 Jun; 87(6):604-7. PubMed ID: 2426566 [TBL] [Abstract][Full Text] [Related]
2. [Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy]. Takesue F; Inutsuka S; Nagahama S; Kusumoto H; Korenaga D; Maekawa S; Ikeda T Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():464-8. PubMed ID: 9589054 [TBL] [Abstract][Full Text] [Related]
3. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9]. Takahashi Y; Mai M Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection. Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311 [TBL] [Abstract][Full Text] [Related]
5. [Study of CEA doubling time in liver metastasis from colonic cancer and postoperative survival time]. Takahashi Y; Kusama S; Mai M; Ueno M; Ogino T; Ueda H; Sawaguchi K Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1422-5. PubMed ID: 3785131 [TBL] [Abstract][Full Text] [Related]
6. Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients. Maehara Y; Tomisaki S; Oda S; Sakaguchi Y; Ichiyoshi Y; Sugimachi K Anticancer Res; 1994; 14(6B):2755-7. PubMed ID: 7872713 [TBL] [Abstract][Full Text] [Related]
7. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence. Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336 [TBL] [Abstract][Full Text] [Related]
8. [The growth rate as a parameter of degree of biological malignancy and prediction of metastasis by tumor marker doubling and half time]. Takahashi Y; Mai M; Kasama S Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1074-7. PubMed ID: 1944157 [TBL] [Abstract][Full Text] [Related]
9. [An autopsy case of a gastric cancer associated with elevated AFP, CEA and CA19-9]. Nakamura Y; Hozumi T; Ohkita M; Masuda S; Maeda M; Okada K; Chinzei T; Yamashiro K; Harui M; Hosokawa I Gan No Rinsho; 1988 Feb; 34(2):213-8. PubMed ID: 2450214 [TBL] [Abstract][Full Text] [Related]
10. Gastric cancer: correlation between clinicopathological factors and survival of patients (III). Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762 [TBL] [Abstract][Full Text] [Related]
11. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345 [TBL] [Abstract][Full Text] [Related]
12. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938 [TBL] [Abstract][Full Text] [Related]
14. [The metastatic patterns of gastric cancer from its histopathological characteristics in the primary lesion--particularly in relation to peritoneal dissemination and liver metastases]. Takahashi Y; Mai M; Ogino T; Ueda H; Kitamura T; Sawaguchi K; Ueno M; Minami S Gan No Rinsho; 1985 Nov; 31(14):1792-6. PubMed ID: 4087385 [TBL] [Abstract][Full Text] [Related]
15. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Chang YC; Nagasue N; Abe S; Taniura H; Kumar DD; Nakamura T Am J Gastroenterol; 1992 Mar; 87(3):321-5. PubMed ID: 1371637 [TBL] [Abstract][Full Text] [Related]
16. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients. Tamura N; Iinuma H; Takada T Oncol Rep; 2007 Mar; 17(3):667-72. PubMed ID: 17273749 [TBL] [Abstract][Full Text] [Related]
17. Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer. Ikeda Y; Mori M; Kajiyama K; Kamakura T; Maehara Y; Haraguchi Y; Sugimachi K Hepatogastroenterology; 1996; 43(11):1281-7. PubMed ID: 8908563 [TBL] [Abstract][Full Text] [Related]
18. [Study on association between the expression of galectin- 3 and the peritoneal metastasis in gastric cancer]. Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):151-4. PubMed ID: 16155829 [TBL] [Abstract][Full Text] [Related]
19. [Prediction of recurrence of gastrointestinal cancer from standpoint of biological malignancies--tumor marker doubling time and its a half life period line]. Mai M; Takahashi Y Hum Cell; 1993 Jun; 6(2):82-7. PubMed ID: 7692953 [TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of tumor markers in patients with colorectal cancer]. Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]